Company:  PROTHENA CORP PLC (PRTA)
Form Type:  4
Filing Date:  5/19/2017 
CIK:  0001559053 
Address:  ADELPHI PLAZA
UPPER GEORGE'S STREET
 
City, State, Zip:  DUN LAOGHAIRE, CO. DUBLIN,  A96 T927 
Telephone:  011-353-1-236-2500 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$46.03  
Change: 
0.18 (0.39%)  
Trade Time: 
01:00 PM EST  
Market Cap: 
$1.77B
Trade PRTA now with 

© 2017  
Description of Business
Prothena Corporation plc is a global, late-stage clinical biotechnology company establishing fully-integrated research, development and commercial capabilities. Fueled by its deep scientific understanding built over decades of research in protein misfolding and cell adhesion - the root causes of many serious or currently untreatable amyloid and inflammatory diseases - Prothena seeks to fundamentally change the course of progressive diseases associated with this biology. Our pipeline of antibody-based product candidates targets a number of potential indications including AL amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004). The company continues discovery of additional novel therapeutic candidates where our deep scientific understanding of disease pathology can be leveraged.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES